Comparison of Bone Mineral Density Changes During Tx With Risperidone or Aripiprazole in Adolescents

NCT00573716 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2011-08-04

No results posted yet for this study

Summary

This study examines if the use of antipsychotic medications might contribute to an interruption in bone mineral development and/or a reduction in bone mineral content in adolescents.

Conditions

  • Psychiatry

Sponsors & Collaborators

Principal Investigators

  • Sriram Ramaswamy, M.D. · Creighton University

Eligibility

Min Age
11 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2009-06-30
Completion
2009-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00573716 on ClinicalTrials.gov